Letter by Spiering et al Regarding Article, "Effect of Denosumab or Alendronic Acid on the Progression of Aortic Stenosis: A Double-Blind Randomized Controlled Trial"

Spiering, Wilko; Mali, Willem P; de Jong, Pim A

doi:https://doi.org/10.1161/CIRCULATIONAHA.121.055622

Letter by Spiering et al Regarding Article, "Effect of Denosumab or Alendronic Acid on the Progression of Aortic Stenosis: A Double-Blind Randomized Controlled Trial"

DSpace/Manakin Repository

Letter by Spiering et al Regarding Article, "Effect of Denosumab or Alendronic Acid on the Progression of Aortic Stenosis: A Double-Blind Randomized Controlled Trial"

Spiering, Wilko; Mali, Willem P; de Jong, Pim A

(2021) Circulation, volume 144, issue 22

(Letter)

Download/Full Text

The full text of this publication is not available.

Version on publisher website for UU-students and staff

Version on publisher website

Keywords: Alendronate, Aortic Valve Stenosis/diagnostic imaging, Denosumab/adverse effects, Double-Blind Method, Humans, Cardiology and Cardiovascular Medicine, Physiology (medical), Comment, Letter

DOI: https://doi.org/10.1161/CIRCULATIONAHA.121.055622

ISSN: 0009-7322

Publisher: Lippincott Williams and Wilkins

(Peer reviewed)